Princeton, New Jersey, United States ProQuest Investments is the famous VC, which was founded in 1998. The venture was found in North America in United States. The main department of described VC is located in the Princeton.
The overall number of key employees were 1.
We can highlight the next thriving fund investment areas, such as Medical, Health Diagnostics. Among the most popular portfolio startups of the fund, we may highlight Pharmion, ReVision Optics, Aerovance. The fund has exact preference in some founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the ProQuest Investments, startups are often financed by Domain Associates, Canaan Partners, Versant Ventures. The meaningful sponsors for the fund in investment in the same round are Versant Ventures, New Enterprise Associates, Canaan Partners. In the next rounds fund is usually obtained by New Enterprise Associates, Domain Associates, Canaan Partners.
The top activity for fund was in 2009. The fund is generally included in 2-6 deals every year. Deals in the range of 10 - 50 millions dollars are the general things for fund. The typical startup value when the investment from ProQuest Investments is 10-50 millions dollars. The top amount of exits for fund were in 2014. Opposing the other organizations, this ProQuest Investments works on 11 percentage points more the average amount of lead investments. The real fund results show that this VC is 3 percentage points more often commits exit comparing to other companies.
Related Funds
Funds with similar focus
| Fund Name | Location |
| 365.fintech | District of Zvolen, Region of Banská Bystrica, Slovakia |
| Apposite Capital | England, London, United Kingdom |
| Harvard Angel Group | Boston, Massachusetts, United States |
| Invivo Capital Partners | Barcelona, Catalonia, Spain |
| Maersk | Copenhagen, Denmark, Hovedstaden |
| Panoramic Ventures | Atlanta, Georgia, United States |
| SHINMEI | Japan, Tokyo |
| Stableton Financial | Switzerland, Zug, Zug |
| The Longevity Fund | California, San Francisco, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Telormedix | $7M | 02 Dec 2013 | Ticino, Switzerland | ||
Immune Design | $49M | 30 Oct 2013 | Seattle, Washington, United States | ||
Mersana Therapeutics | $27M | 31 Jul 2012 | Cambridge, Massachusetts, United States | ||
Agile Therapeutics | $40M | 19 Jul 2012 | New Jersey, United States | ||
Telormedix | $6M | 25 Jan 2012 | Ticino, Switzerland | ||
Aires Pharmaceuticals | $20M | 11 Nov 2010 | San Diego, California, United States | ||
Immune Design | $32M | 26 Jul 2010 | Seattle, Washington, United States | ||
Predictive Biosciences | $25M | 18 Jun 2010 | Massachusetts, United States | ||
Agile Therapeutics | $45M | 14 Jun 2010 | New Jersey, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Telormedix | $7M | 02 Dec 2013 | Ticino, Switzerland | ||
Immune Design | $49M | 30 Oct 2013 | Seattle, Washington, United States | ||
Mersana Therapeutics | $27M | 31 Jul 2012 | Cambridge, Massachusetts, United States | ||
Agile Therapeutics | $40M | 19 Jul 2012 | New Jersey, United States | ||
Telormedix | $6M | 25 Jan 2012 | Ticino, Switzerland | ||
Aires Pharmaceuticals | $20M | 11 Nov 2010 | San Diego, California, United States | ||
Immune Design | $32M | 26 Jul 2010 | Seattle, Washington, United States | ||
Predictive Biosciences | $25M | 18 Jun 2010 | Massachusetts, United States | ||
Agile Therapeutics | $45M | 14 Jun 2010 | New Jersey, United States |
